Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
2,930,364
-
Share change
-
-53,464
-
Total reported value
-
$291,496,084
-
Put/Call ratio
-
62%
-
Price per share
-
$99.71
-
Number of holders
-
110
-
Value change
-
-$4,711,885
-
Number of buys
-
42
-
Number of sells
-
56
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2016
As of 30 Sep 2016,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,930,364 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, AMERIPRISE FINANCIAL INC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, ROYAL BANK OF CANADA, J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD, and McKinley Carter Wealth Services, Inc..
This page lists
110
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.